[AsCNP_O2] Oral Session 2
Childhood & Adolescent Disorders

[AsCNP-O2-4] Role of cerebrospinal fluid ethanolamine in psychiatric disorders

^○Shintaro OGAWA¹, Kotaro HATTORI^{1, 2}, Daimei SASAYAMA³, Tomoko MIYAKAWA², Megumi TATSUMI^{1, 2}, Sumiko YOSHIDA⁴, Hiroshi KUNUGI¹ (1. Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan, 2. Medical Genome Center, National Center of Neurology and Psychiatry, Tokyo, Japan, 3. Department of Psychiatry, Shinshu University School of Medicine, Nagano, Japan, 4. Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan)